MedTrace Logo

Does a Nasal Instillation of Miglustat Normalize the Nasal Potential Difference in Cystic Fibrosis Patients ?

NCT00945347 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2011-08-10

No results posted yet for this study

Summary

The purpose of this study is to investigate within a short delay the effect of nasal instillation of Miglustat on nasal potential difference in cystic fibrosis patients homozygous for the F508del mutation.

Conditions

Interventions

DRUG

Miglustat

Nasal instillation of miglustat

DRUG

Placebo

Nasal instillation of placebo matching in appearance with the Miglustat instillation

Sponsors & Collaborators

  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain

    lead OTHER

Principal Investigators

  • Patrick LEBECQUE, MD, PhD · Cliniques Universitaires St Luc (Université Catholique de Louvain )

  • Teresinha LEAL, MD, PhD · Cliniques Universitaires St. Luc ( Université Catholique de Louvain)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2011-05-31
Completion
2011-06-30

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00945347 on ClinicalTrials.gov